Medigenix connects global licensors, manufacturers and investors with the Turkish pharmaceutical market — from pipeline mapping and dossier sourcing to launch, sales and digital marketing — with speed to market.
Whether you hold a registered dossier, a development-stage asset or a manufacturing capability, we find the right counterpart, structure the partnership and carry it through to launch.
Medigenix looks for licensors seeking a route into the Turkish market, and runs the commercial side of the launch.
Portfolio strategy grounded in ATC-segment justification, then execution across the three sourcing routes.
Account management for licensors and alliance partners over the whole life of the agreement.
Content and channel strategy built for physicians and the pharmacy channel.
Our partnering and launch experience spans nine therapeutic areas, from complex oncology and haematology molecules to OTC and food-supplement brands.
A partnership is only as good as the sequence that builds it. We move through six stages, each with a clear output the partner can act on.
Justify the ATC segments with a BCG-style portfolio view; define target segments, customers and the business model, including production services.
Map and prioritise dossiers and partners; complete due diligence; structure profit-sharing, in-licensing or CMO models with a solid, low-risk financial case.
Negotiate and close with licensors, CDMOs, CMOs or investors; align quality, regulatory and supply so registration and technology transfer run without surprises.
Launch excellence in Türkiye, sales-force and digital execution, then expansion through export alliances, add-on complex molecules and biosimilar or biotech opportunities.
Ongoing licensor and account management: governance, forecasting, performance reviews and the next product from the same partner.
M&A and portfolio-acquisition support for partners that want to build capability rather than only license, up to large-ticket transactions.
Pharmacist · Commercial Pharma Expert
Kerim founded Medigenix to create a health ecosystem around one idea: value-added pharmaceutical products reach patients faster when the right partners are connected early. He brings more than 20 years of experience in marketing and sales, team leadership, strategy and business development, with full P&L and people-management responsibility, including over 12 years in director-level roles on management boards. His commercial experience covers specialty care across diabetes and obesity, cardiology, oncology, ophthalmology, CNS, respiratory and dermatology, as well as consumer products and food supplements. He has led mergers, acquisitions and portfolio purchases with ticket sizes up to USD 135 million, designed company pipelines and product portfolios, and built and managed large-scale global licensor relationships, working hand in hand with finance, R&D, regulatory, quality, market-access and HR teams.
With more than 20 years of hands-on experience in pharmaceutical marketing, sales and business development — across multinational companies and local market leaders — our founder brings a rare combination of scientific rigour and commercial acumen to every partnership.
We work as a trusted extension of your team: from the first market-entry analysis through to ongoing alliance management, always with a focus on speed to market and sustainable return.
Whether you are a global licensor looking for a Turkish market entry, a manufacturer seeking a distribution partner, or an investor evaluating pharma opportunities in Türkiye — we would like to hear from you.